Health Care [ 5/12 ] | Biotechnology [ 25/74 ]
NASDAQ | Common Stock
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS).
It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma.
It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia.
Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 11, 25 | -0.28 Increased by +86.63% | -0.43 Increased by +35.33% |
| Nov 7, 24 | -0.47 Increased by +75.90% | -0.49 Increased by +4.08% |
| Aug 8, 24 | -0.39 Increased by +81.69% | -0.61 Increased by +36.07% |
| May 9, 24 | -1.11 Decreased by -226.47% | -0.76 Decreased by -46.05% |
| Mar 13, 24 | -2.08 Decreased by -407.32% | -2.31 Increased by +9.96% |
| Nov 8, 23 | -1.95 Decreased by -107.45% | -2.72 Increased by +28.31% |
| Aug 2, 23 | -2.13 Increased by +34.26% | -2.82 Increased by +24.47% |
| May 8, 23 | -0.34 Increased by +86.40% | -0.28 Decreased by -21.43% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 0.00 Decreased by -100.00% | -2.31 M Decreased by -11.54% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -2.35 M Decreased by -21.97% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -1.97 M Increased by +6.65% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -2.35 M Increased by +1.30% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 154.77 K Increased by +N/A% | -2.07 M Decreased by -4.92% | Decreased by -1.34 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -1.93 M Increased by +48.53% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -2.11 M Increased by +21.03% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -2.38 M Decreased by -100.42% | Decreased by N/A% Decreased by N/A% |